Summary
E. I. du Pont de Nemours and Company (DuPont) filed its 2001 Form 10-K on March 20, 2002, detailing its operations and financial condition as of December 31, 2001. The report highlights the company's diverse business segments, including Agriculture & Nutrition, Nylon, Performance Coatings & Polymers, Pharmaceuticals, Pigments & Chemicals, Polyester, Specialty Fibers, and Specialty Polymers. A significant event during the year was the sale of DuPont Pharmaceuticals to Bristol-Myers Squibb Company, though DuPont retained an interest in the Cozaar® and Hyzaar® brands. The company also continues to manage the divestiture of its former petroleum business, Conoco Inc., as discontinued operations. DuPont emphasizes its global reach, with operations in approximately 75 countries and roughly half of its consolidated sales generated outside the United States. The company is a leader in science and technology across various sectors. In February 2002, DuPont announced a realignment of its businesses into five growth platforms and plans to create a Textiles and Interiors subsidiary, signaling strategic shifts aimed at future growth and market focus. Investors should note the ongoing legal proceedings, particularly those related to the Benlate® fungicide, which, while potentially significant to future results, are not anticipated to materially impact the company's overall financial position or liquidity. The company also faces potential market risks from raw material cost fluctuations, geopolitical events, and the success of new product development.
Key Highlights
- 1Significant divestiture of DuPont Pharmaceuticals completed on October 1, 2001, with retained interests in key brands (Cozaar®, Hyzaar®).
- 2Announced strategic realignment into five market- and technology-focused growth platforms and plans to create a Textiles and Interiors subsidiary by year-end 2003.
- 3Global operations in approximately 75 countries, with about 50% of consolidated sales outside the United States.
- 4Operates through eight reportable segments: Agriculture & Nutrition, Nylon, Performance Coatings & Polymers, Pharmaceuticals, Pigments & Chemicals, Polyester, Specialty Fibers, and Specialty Polymers.
- 5Ongoing legal proceedings related to Benlate® fungicide, with management not anticipating a material adverse effect on the company's consolidated financial position or liquidity, despite potential significance to period results.
- 6The company is a world leader in science and technology, operating in sectors including high-performance materials, synthetic fibers, electronics, specialty chemicals, agriculture, and biotechnology.
- 7Year-end 2001 global employment stood at approximately 79,000 people.